Back to top

Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away?
October 05, 2017

Read MoreHide Full Article

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Glaukos Corporation (GKOS - Free Report) , which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #4 (Sell) further confirms weakness in GKOS.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen seven estimates moving down in the past 30 days, compared with just no upward revisions. This trend has caused the consensus estimate to trend lower, going from 9 cents a share a month ago to its current level of 1 cent.

Also, for the current quarter, Glaukos has seen four downward estimate revisions versus no revisions in the opposite direction, dragging the consensus estimate down to break-even level from 3 cents a share over the past 30 days.

The stock also has seen some pretty dismal trading lately, as the share price has dropped 14.9% in the past month.

Glaukos Corporation Price and Consensus

 

Glaukos Corporation Price and Consensus | Glaukos Corporation Quote

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the Medical - Instruments industry, you may instead consider a better-ranked stock - EnteroMedics Inc. . The stock currently holds a Zacks Rank #1 (Strong Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank stocks here.

4 Stocks to Watch after the Massive Equifax Hack

Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?

Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.

Get the new Investing Guide now>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Glaukos Corporation (GKOS) - free report >>


More from Zacks Tale of the Tape

You May Like